Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
接受teclistamab治疗的多发性骨髓瘤患者的临床结局和巨细胞病毒再激活的危险因素
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-026-01484-0
Cheema, Hira; Shrestha, Asis; Naqvi, Syed; Muttineni, Sanjay; Dronavalli, Sasya; Alrawabdeh, Jawad; Alzu'bi, Marah; Schinke, Carolina D; Thanendrarajan, Sharmilan; Shaughnessy, John D Jr; Zhan, Fenghuang; Zangari, Maurizio; van Rhee, Frits; Hadidi, Samer Al